Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization

NCT05347069 is registered in ClinicalTrials.gov with Takeshi Morimoto as lead sponsor.

NCT NCT05347069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05347069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
Lead sponsor
Takeshi Morimoto
Phase
Phase 4
Overall status
Recruiting
Start date
June 14, 2022
Completion date
December 31, 2030
Enrollment
2,890 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, ischemic heart disease, stable angina pectoris